ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Hot Features

Registration Strip Icon for discussion Registrieren Sie sich, um in unseren aktiven Foren mit gleichgesinnten Anlegern zu diskutieren.

LNTH Lantheus Holdings Inc

81,18
0,08 (0,10%)
Zuletzt aktualisiert: 16:40:03
Verzögert um 15 Minuten
Name Symbol Markt Aktientyp
Lantheus Holdings Inc LNTH NASDAQ Common Stock
  Änderung Änderung % Aktuell Zeit
0,08 0,10% 81,18 16:40:03
Handelsbeginn Niedrig Hoch Schlusskurs Handelsende
81,34 80,75 82,10 81,10
more quote information »

Aktuelle News

Datum Zeit Quelle Überschrift
15.5.202423:09EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15.5.202422:43EDGAR2Form 8-K - Current report
15.5.202422:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15.5.202422:30GLOBELantheus Announces Executive Appointments to Accelerate..
13.5.202423:11EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13.5.202423:11EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13.5.202423:07EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13.5.202423:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13.5.202423:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13.5.202417:19EDGAR2Form 144 - Report of proposed sale of securities
02.5.202413:00GLOBELantheus Reports First Quarter 2024 Financial Results
18.4.202414:00GLOBELantheus to Host First Quarter 2024 Earnings Conference Call..
11.3.202421:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07.3.202422:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07.3.202422:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07.3.202422:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07.3.202422:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07.3.202422:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07.3.202422:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07.3.202416:46EDGAR2Form 144 - Report of proposed sale of securities
06.3.202402:35EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06.3.202402:28EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06.3.202402:27EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06.3.202402:21EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06.3.202402:20EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06.3.202402:14EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06.3.202401:38EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05.3.202414:30GLOBELantheus to Present at the Leerink Partners Global Biopharma..
04.3.202423:44EDGAR2Form 144 - Report of proposed sale of securities
04.3.202414:30GLOBELantheus Announces the FDA Approval of DEFINITY® (Perflutren..
28.2.202414:30GLOBELantheus Announces Promotion of Amanda Morgan to Chief..
26.2.202414:30GLOBELantheus to Present at the TD Cowen 44th Annual Health Care..
22.2.202413:49EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
22.2.202413:47EDGAR2Form 8-K - Current report
22.2.202413:00GLOBELantheus Reports Fourth Quarter and Full Year 2023 Financial..
15.2.202422:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13.2.202416:18EDGAR2Form 144 - Report of proposed sale of securities
13.2.202414:30GLOBELantheus Announces Collaboration to Provide Novel Tau..
08.2.202414:00GLOBELantheus to Host Fourth Quarter and Full Year 2023 Earnings..
26.1.202413:59EDGAR2Form 8-K - Current report
23.1.202414:00EDGAR2Form 8-K - Current report
23.1.202413:45GLOBELantheus Announces CEO Succession Plan
18.1.202422:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16.1.202418:05EDGAR2Form 144 - Report of proposed sale of securities
11.1.202414:00GLOBELantheus Announces Acceptance of its First-to-File ANDA for..
09.1.202414:00GLOBELantheus Expands Radiopharmaceutical Oncology Pipeline via..
09.1.202413:57EDGAR2Form 8-K - Current report
09.1.202413:55GLOBELantheus Reports Preliminary Fiscal Year 2023 Revenue
03.1.202414:30GLOBELantheus to Present at the 42nd Annual J.P. Morgan..
19.12.202323:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..

Kürzlich von Ihnen besucht

Delayed Upgrade Clock